|Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age|
P Bejon, J Lusingu, A Olotu, A Leach, M Lievens, J Vekemans, S Mshamu, ...
New England Journal of Medicine 359 (24), 2521-2532, 2008
|Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure|
A Olotu, G Fegan, J Wambua, G Nyangweso, KO Awuondo, A Leach, ...
New England Journal of Medicine 368 (12), 1111-1120, 2013
|Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children|
A Olotu, G Fegan, J Wambua, G Nyangweso, A Leach, M Lievens, ...
New England Journal of Medicine 374 (26), 2519-2529, 2016
|Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya|
P Bejon, TN Williams, A Liljander, AM Noor, J Wambua, E Ogada, A Olotu, ...
PLoS medicine 7 (7), e1000304, 2010
|Efficacy of RTS, S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a …|
A Olotu, J Lusingu, A Leach, M Lievens, J Vekemans, S Msham, T Lang, ...
The Lancet infectious diseases 11 (2), 102-109, 2011
|The relationship between RTS, S vaccine-induced antibodies, CD4+ T cell responses and protection against Plasmodium falciparum infection|
MT White, P Bejon, A Olotu, JT Griffin, EM Riley, KE Kester, ...
PloS one 8 (4), e61395, 2013
|Efficacy of RTS, S malaria vaccines: individual-participant pooled analysis of phase 2 data|
P Bejon, MT White, A Olotu, K Bojang, JPA Lusingu, N Salim, NN Otsyula, ...
The Lancet infectious diseases 13 (4), 319-327, 2013
|Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children|
FM Ndungu, A Olotu, J Mwacharo, M Nyonda, J Apfeld, LK Mramba, ...
Proceedings of the National Academy of Sciences 109 (21), 8247-8252, 2012
|Circumsporozoite-specific T cell responses in children vaccinated with RTS, S/AS01E and protection against P falciparum clinical malaria|
A Olotu, P Moris, J Mwacharo, J Vekemans, D Kimani, M Janssens, O Kai, ...
PloS one 6 (10), e25786, 2011
|Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children|
P Bejon, J Cook, E Bergmann-Leitner, A Olotu, J Lusingu, J Mwacharo, ...
Journal of Infectious Diseases 204 (1), 9-18, 2011
|Wind direction and proximity to larval sites determines malaria risk in Kilifi District in Kenya|
JT Midega, DL Smith, A Olotu, JM Mwangangi, JG Nzovu, J Wambua, ...
Nature communications 3, 674, 2012
|Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial|
MA Thera, OK Doumbo, D Coulibaly, MB Laurens, AK Kone, AB Guindo, ...
PloS one 5 (2), e9041, 2010
|Advancing global health through development and clinical trials partnerships: a randomized, placebo-controlled, double-blind assessment of safety, tolerability, and …|
A Olotu, V Urbano, A Hamad, M Eka, M Chemba, E Nyakarungu, J Raso, ...
The American journal of tropical medicine and hygiene 98 (1), 308-318, 2018
|A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS, S malaria vaccine|
MT White, P Bejon, A Olotu, JT Griffin, K Bojang, J Lusingu, N Salim, ...
BMC medicine 12 (1), 117, 2014
|Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites|
P Bejon, L Turner, T Lavstsen, G Cham, A Olotu, CJ Drakeley, M Lievens, ...
PloS one 6 (6), e21711, 2011
|Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast|
SM Kariuki, M Ikumi, J Ojal, M Sadarangani, R Idro, A Olotu, P Bejon, ...
Brain 134 (5), 1519-1528, 2011
|A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS, S/AS01E|
FM Ndungu, J Mwacharo, D Kimani, O Kai, P Moris, E Jongert, ...
PLoS One 7 (12), e52870, 2012
|Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya|
A Olotu, G Fegan, TN Williams, P Sasi, E Ogada, E Bauni, J Wambua, ...
PLoS One 5 (12), e15569, 2010
|Estimating individual exposure to malaria using local prevalence of malaria infection in the field|
A Olotu, G Fegan, J Wambua, G Nyangweso, E Ogada, C Drakeley, ...
PloS one 7 (3), e32929, 2012
|Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS, S malaria vaccine: analysis of pooled phase II clinical trial data|
GM Warimwe, HA Fletcher, A Olotu, ST Agnandji, AVS Hill, K Marsh, ...
BMC medicine 11 (1), 184, 2013